GB2269319B - Methods for administration of taxol - Google Patents

Methods for administration of taxol

Info

Publication number: GB2269319B
Authority: GB; United Kingdom
Prior art keywords: taxol; administration; methods
Prior art date: 1992-08-03
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

GB9315054A

Other versions

GB2269319A (en

GB9315054D0 (en

Inventor

Renzo M Canetta

Marcel Rozencweig

Elizabeth Eisenhauer

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Bristol Myers Squibb Co

Original Assignee

Bristol Myers Squibb Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-08-03

Filing date

1993-07-20

Publication date

1997-04-09

1993-06-07 Priority claimed from GB939311740A external-priority patent/GB9311740D0/en

1993-07-20 Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co

1993-09-01 Publication of GB9315054D0 publication Critical patent/GB9315054D0/en

1994-02-09 Publication of GB2269319A publication Critical patent/GB2269319A/en

1997-04-09 Application granted granted Critical

1997-04-09 Publication of GB2269319B publication Critical patent/GB2269319B/en

2013-07-20 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/193—Colony stimulating factors [CSF]

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

GB9315054A 1992-08-03 1993-07-20 Methods for administration of taxol Expired - Lifetime GB2269319B (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US92362892A	1992-08-03	1992-08-03
GB939311740A GB9311740D0 (en)	1992-08-03	1993-06-07	Methods for administration of taxol

Publications (3)

Publication Number	Publication Date
GB9315054D0 GB9315054D0 (en)	1993-09-01
GB2269319A GB2269319A (en)	1994-02-09
GB2269319B true GB2269319B (en)	1997-04-09

Family

ID=26303019

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GB9315054A Expired - Lifetime GB2269319B (en)	1992-08-03	1993-07-20	Methods for administration of taxol

Country Status (3)

Country	Link
CY (1)	CY2049B1 (en)
GB (1)	GB2269319B (en)
HK (1)	HK116397A (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1992019765A1 (en) *	1991-05-08	1992-11-12	The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services	Method for designing cancer treatment regimens and methods and pharmaceutical compositions for the treatment of cancer
WO1993000929A1 (en) *	1991-07-08	1993-01-21	Rhone-Poulenc Rorer S.A.	Novel compositions based on taxane class derivatives

1993
- 1993-07-20 GB GB9315054A patent/GB2269319B/en not_active Expired - Lifetime
1997
- 1997-06-26 HK HK116397A patent/HK116397A/en not_active IP Right Cessation
1998
- 1998-04-30 CY CY9802049A patent/CY2049B1/en unknown

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1992019765A1 (en) *	1991-05-08	1992-11-12	The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services	Method for designing cancer treatment regimens and methods and pharmaceutical compositions for the treatment of cancer
WO1993000929A1 (en) *	1991-07-08	1993-01-21	Rhone-Poulenc Rorer S.A.	Novel compositions based on taxane class derivatives

Non-Patent Citations (11)

* Cited by examiner, † Cited by third party
Title
Annals of Oncology Vol.3, Supp. 1, 1992, Nos. 224 & 225 *
Biosis Number 91121038 and Investigational New Drugs 9(1), 1991,pages 59-64 *
CA 115(18):189573w & American J. Hospital Pharm. 48 (7), 1520-1524, 1991 *
Cancer Investigation,9 (2),1991,pages 133-136 *
Cancer Research (47),May 1987,pages 2486-2493 *
Cancer Vol. 65, No.11, 1990, pages 2478-81 *
Embase Number 86155068 and Cancer Treat.Rep. 1986, 70/5, pages 605-607 *
J. Clinical Oncology Vol. 10, No.7,1992, pages 1165-69 *
J. Clinical Oncology Vol. 8, No.7,1990, pages 1263-68 *
Medline Number 88080135 and Cancer Treat.Rep. 71(12), 1987,pages 1179-1184 *
Proceedings American Association of Cancer Research 26 : 167 (1985) *

Also Published As

Publication number	Publication date
GB2269319A (en)	1994-02-09
HK116397A (en)	1997-09-05
GB9315054D0 (en)	1993-09-01
CY2049B1 (en)	1998-04-30

Publication	Publication Date	Title
ZA936723B (en)	1995-08-14	Pharmaceutical preparations for lowering homocysteine levels
PH30215A (en)	1997-02-05	Pharmaceutical compounds
IL126178A0 (en)	1999-05-09	Methods for stabilizing compositions containing taxol and pharmaceutical compositions containing taxol prepared
HU9301714D0 (en)	1993-09-28	Method for producing benmzimidazole derivatives and pharmaceutical preparatives containing said compounds
GB9204354D0 (en)	1992-04-08	Compounds for medicinal use
ZA939317B (en)	1995-06-13	Medicament
HU9303261D0 (en)	1994-03-28	Pharmaceutical compounds
ZA931944B (en)	1994-09-18	Pharmaceutical compounds
HU9301580D0 (en)	1993-09-28	Phenyl-furoxanes and methods for producing said compounds and pharmaceutical preparatives containing them
GB2269319B (en)	1997-04-09	Methods for administration of taxol
GB9224169D0 (en)	1993-01-06	Pharmaceutical compounds
GB9304549D0 (en)	1993-04-21	Apparatus for administration of drugs
AU5239493A (en)	1994-03-17	Methods for administration of taxol
GB9226724D0 (en)	1993-02-17	Pharmaceutical compounds
ZA945651B (en)	1996-01-29	Use of benzenesulphonzlindole derivatives for the preparation of medicines
GB9211379D0 (en)	1992-07-15	Pharmaceutical compounds
BG96767A (en)	1995-10-31	Method for the preparation of an antitumour medicament
ZA933356B (en)	1993-11-22	Pharmaceutical compostions
BG94585A (en)	1995-05-31	Method for the preparation of an analgesic medicament
GB9204767D0 (en)	1992-04-15	Medicament
GB9214905D0 (en)	1992-08-26	Medicament
GB9218090D0 (en)	1992-10-14	Pharmaceutical compounds
GB9222650D0 (en)	1992-12-09	Pharmaceutical compounds
GB9218112D0 (en)	1992-10-14	Pharmaceutical compounds
ZA931332B (en)	1994-08-25	Pharmaceutical compounds

Legal Events

Date	Code	Title
1998-03-25	729S	Offer to surrender (sect. 29/1977)
1998-07-01	729U	Offer to surrender accepted by the comptroller (sect. 29/1977)
1998-07-08	729U	Offer to surrender accepted by the comptroller (sect. 29/1977)